Peer-influenced content. Sources you trust. No registration required. This is HCN.

Ciclesonide May Be Promising Outpatient Therapy for Early COVID-19

There are currently no effective antiviral agents available for the treatment of COVID-19 in the outpatient setting. However, ciclesonide, an inhaled steroid agent used to treat asthma, has been found to lessen the antiviral effects by acting on the nonstructural proteins of COVID-19.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form